Definition/General

Introduction:
-Primary neuroendocrine carcinoma (NEC) of the breast is a rare tumor type, characterized by the expression of neuroendocrine markers in more than 50% of the tumor cells
-It is a heterogeneous group of tumors with varying prognoses.
Origin:
-The origin is thought to be from neuroendocrine cells that are occasionally found in the normal breast epithelium, or from the neuroendocrine differentiation of a conventional adenocarcinoma.
Classification:
-According to the WHO, breast NECs are classified into well-differentiated neuroendocrine tumor (NET), poorly differentiated neuroendocrine carcinoma (NEC) (which includes small cell and large cell types), and invasive carcinoma with neuroendocrine differentiation.
Epidemiology:
-These tumors are rare, accounting for less than 1% of all breast cancers
-They are more common in older women.

Clinical Features

Presentation:
-Presents as a palpable breast mass, similar to adenocarcinoma NST
-Carcinoid syndrome is extremely rare.
Symptoms: A painless breast lump is the most common symptom.
Risk Factors: The risk factors are similar to those for conventional breast cancer.
Screening: Mammographic and ultrasound findings are non-specific.

Master Breast NEC Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-A well-circumscribed, firm, tan-yellow mass.
Characteristics:
-Size is variable
-Necrosis can be present in high-grade tumors.
Size Location: Can occur anywhere in the breast.
Multifocality: Uncommon.

Microscopic Description

Histological Features:
-Well-differentiated NETs show organoid patterns like nests and trabeculae, with cells having "salt-and-pepper" chromatin
-Poorly differentiated NECs (small cell or large cell) show sheets of highly atypical cells with high mitotic activity and necrosis.
Cellular Characteristics:
-The tumor cells are monotonous with scant cytoplasm and granular chromatin
-In high-grade tumors, the cells are pleomorphic with high N/C ratios.
Architectural Patterns:
-Nesting, trabecular, and solid patterns are common
-Rosette formation can be seen.
Grading Criteria:
-Grading is based on mitotic count and Ki-67 index, similar to neuroendocrine tumors elsewhere.

Immunohistochemistry

Positive Markers:
-The diagnosis requires positivity for neuroendocrine markers such as synaptophysin and chromogranin A in >50% of cells
-Most tumors are ER-positive.
Negative Markers: HER2 is usually negative.
Diagnostic Utility:
-IHC is essential for diagnosis
-It is also important to exclude a metastasis from a neuroendocrine tumor elsewhere (e.g., lung, GI tract).
Molecular Subtypes: Most are of the Luminal A or B molecular subtype.

Molecular/Genetic

Genetic Mutations:
-The molecular profile is similar to that of ER-positive breast cancer, with frequent mutations in PIK3CA and GATA3.
Molecular Markers: No specific molecular markers are routinely used for diagnosis.
Prognostic Significance:
-The prognosis is variable
-Well-differentiated NETs have a relatively good prognosis, similar to grade-matched adenocarcinoma NST
-Poorly differentiated NECs have a poor prognosis.
Therapeutic Targets:
-Treatment is similar to that of conventional breast cancer, based on ER and HER2 status
-Endocrine therapy is often used
-Somatostatin analogues can be used in some cases.

Differential Diagnosis

Similar Entities:
-Metastatic neuroendocrine tumor
-Adenocarcinoma NST with focal neuroendocrine differentiation
-Solid papillary carcinoma.
Distinguishing Features:
-Excluding a metastasis is crucial
-Adenocarcinoma with focal neuroendocrine differentiation has <50% of cells positive for neuroendocrine markers
-Solid papillary carcinoma can have neuroendocrine features but has a characteristic papillary architecture.
Diagnostic Challenges:
-The main challenge is to distinguish primary from metastatic neuroendocrine tumors
-The >50% cutoff for neuroendocrine marker expression is key for diagnosis.
Rare Variants: Small cell carcinoma of the breast is a very rare and aggressive variant.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

[specimen type], measuring [size] cm in greatest dimension

Diagnosis

[diagnosis name]

Classification

Classification: [classification system] [grade/type]

Histological Features

Shows [architectural pattern] with [nuclear features] and [mitotic activity]

Size and Extent

Size: [X] cm, extent: [local/regional/metastatic]

Margins

Margins are [involved/uninvolved] with closest margin [X] mm

Lymphovascular Invasion

Lymphovascular invasion: [present/absent]

Lymph Node Status

Lymph nodes: [X] positive out of [X] examined

Special Studies

IHC: [marker]: [result]

Molecular: [test]: [result]

[other study]: [result]

Final Diagnosis

Final diagnosis: [complete diagnosis]